Today’s AI Top Pick: AREC
7/13/2026 · Contrarian screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live AREC price forecast →
American Resources (AREC) is the cleanest contrarian bounce setup in the pool: every single timeframe forecast is positive (1h short +10.76%/mid +25.37%/long +27.65%; 4h +5.91/+31.19/+57.01; 1d +5.92/+41.02/+40.94; 1wk +26.32/+26.53/+19.89), the stock is pinned at pos_in_21bar_range = 0% on 1h/4h/1d/1wk (i.e., it can't get lower without breaking to new lows), and the drawdown (-18.9% pool, -20.94% on 1d, -40.97% on 1wk) is being met by a MODEL bullish_prob of 1.0 with near_term_bullish 0.8. That's the definition of exhausted selling with the tape turning. What pushes AREC above the other clean charts (BLDR, FLYX, IMSR) is a hard, dated positive catalyst: on 2026-07-09 AREC was selected by the U.S. Department of Energy for award negotiations on a rare earth recovery pilot project, and Insider Monkey ran a follow-up piece on its battery recycling buildout. This is exactly the kind of headline that flips a downtrend — a real government-backed program on a critical-minerals thesis into a stock that's already washed out. Contrast this with the top of the forecast pack — MBRX (trial data missed significance), UNCY (FDA CRL), IVVD (FDA EUA termination), ALEC (GSK walked away), SSTK (Getty deal terminated), and ILLR (Nasdaq compliance/halt) — all of which have model forecasts undercut by material negative news and are not investable dip-buys today. Fundamentally AREC is not pretty (PS 1925, huge negative margins, sales -76% YoY), but the fundamental_score is a mild +3.25 because analyst recom is 1.0 and target upside is 177.8%, debt/equity is essentially nil (light balance-sheet risk), and epsNextY is +343%. In a contrarian-bounce lens where we're buying model conviction on a wash-out, the combination of (a) zero position in range across every timeframe, (b) all-positive multi-horizon forecasts, and (c) a concrete DOE catalyst is stronger than either the higher-quality but pre-earnings BLDR or the smaller-cap FLYX/BCDA setups. Today is the right entry rather than waiting because the 1h forecast is already up (+10.76%) and 1h pos_in_range is 0 — meaning we are at or near the lower bound and the near-term forecast is turning. Waiting risks buying after the DOE-catalyst gap-up; a stop just below the 21-bar low keeps the risk defined.
- PS ratio 1925 and profit margin -39,087% — this is a pre-revenue speculative name; any secondary offering could crush the trade (market cap only $192M)
- Sales YoY -76.24% — DOE selection is 'award negotiations,' not a signed contract; deal could collapse and unwind the +26-57% forecasts
- Short float 15.72% cuts both ways — squeeze fuel on catalyst, but heavy selling if DOE story slips
- 1wk drawdown -40.97% and dd_from_21bar_high -43.6% means the weekly trend is still broken; a failed bounce reverts to lower lows fast
- Small-cap basic materials with instOwn only 27% — thin liquidity, wide spreads, gap risk
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | AREC | BUY NOW | 8.6 | All-timeframes-up forecasts + 0% pos_in_range on every TF + hard DOE catalyst = textbook exhausted-selling bounce. |
| 2 | BLDR | BUY NOW | 7.8 | Only quality large-cap in the pool with all-TF bullish forecasts and pos_in_range 8-15%; only drag is earnings binary. |
| 3 | FLYX | BUY NOW | 7.2 | All-TF positive, pos_in_range 0% on 1h/4h/1d/1wk, and Jet.AI deal closed as catalyst. |
| 4 | IMSR | BUY NOW | 6.9 | Nuclear/SMR narrative intact, 1d fc_short +47%, positive SeekingAlpha thesis, cash-floor argument limits downside. |
| 5 | BCDA | BUY PULLBACK | 6.6 | Huge 1wk forecast (+88/+193/+229%) and Japan PMDA milestone, but $13M cap and ROE -950% demand a pullback entry. |
| 6 | EOSE | BUY PULLBACK | 6.4 | 1d +26/+68/+78, Frontier Power project selection is real, but 1wk mid forecast -14% flags near-term chop. |
| 7 | OPTT | BUY PULLBACK | 6.1 | 1d +33.96/+84.74/+77.1 with European maritime security wins; pos_in_range near 0 on 1h/4h helps. |
| 8 | CWH | BUY PULLBACK | 5.7 | Strong 1d/1wk forecast (+42/+75/+67 and +72/+188/+190), but recent analyst target cuts and 'declining sales' articles cap conviction. |
| 9 | RDZN | BUY PULLBACK | 5.6 | Fund score 5.5 highest in pool, positive acquisition/contract news, but 1h pos_in_range 66% means don't chase. |
| 10 | TGEN | WAIT | 5.0 | $3.3M order is nice, but 1wk fc turns sharply negative (-19.5/-39.59/-54.26) — model disagrees with itself across horizons. |
| 11 | BIRD | WAIT | 4.8 | 1d fc +66/+73/+90 and rebrand catalyst, but 1wk forecast -30/-32/-34 and fund score -3 undercut it. |
| 12 | ANY | WAIT | 4.6 | 1d fc +58/+144/+141 is huge, but no 1wk data and a rebrand-to-crypto story adds narrative volatility. |
| 13 | OEC | WAIT | 4.4 | 1wk fc +73/+135/+186 impressive, but 1h pos_in_range 91% means near-term extended — wait for a pullback. |
| 14 | ARQQ | WAIT | 4.2 | Post-settlement rally leaves 1d already +38.8% on 21bar and 1h forecast turning NEGATIVE (-12%) — bounce already priced. |
| 15 | FABC | WAIT | 4.0 | 1wk fc +235/+348/+128 is eye-popping, but 187M-share resale prospectus is dilution overhang. |
| 16 | OPTU | WAIT | 3.8 | 1d fc +46/+85/+74 solid but 1wk fades to +2.39 long, fund_score -0.25, targetUpside only 14%. |
| 17 | AIIO | WAIT | 3.6 | Interpol chairman headline is exotic, 4h forecast negative across horizons; too speculative for lead pick. |
| 18 | SFIX | WAIT | 3.4 | 1d fc +14/+27/+18 modest, CFO selling and Zacks 'down 16.2%' article makes it a laggard buy. |
| 19 | EDGE-USD | WAIT | 3.3 | Crypto with only 1h/4h data and near_term_bullish 0.2 — insufficient signal vs. equity setups. |
| 20 | MBRX | AVOID | 3.0 | MIRACLE trial data missed significance on 6/30 (-25%); forecast is fighting fresh bad news. |
| 21 | SSTK | AVOID | 2.9 | Getty $3.7B combination TERMINATED on 7/7 — the +94/+109/+125% forecast is a stale model versus a broken catalyst. |
| 22 | BLNE | AVOID | 2.7 | 1wk forecast -60/-60/-60 and 1wk drawdown -60% — the model itself says the weekly trend is broken. |
| 23 | GELS | WAIT | 2.5 | $5.6M cap micro, no near-term catalyst, fund score -2.5. |
| 24 | LASE | WAIT | 2.4 | REXA order positive but ROE -727%, profitMargin -507%, and no MTF data provided. |
| 25 | BTAI | AVOID | 2.2 | 1wk fc -49.97/-49.97/-49.97 flatlined negative; operMargin -7344% — model + fundamentals both scream broken. |
| 26 | IVVD | AVOID | 2.0 | FDA sent EUA termination notice for Pemgarda on 7/6 — the forecast's +34/+71/+78 assumes news that already broke bad. |
| 27 | UNCY | AVOID | 1.7 | FDA CRL on 7/1 dropped stock 33.1%; analysts cut targets — do not catch a regulatory rejection knife. |
| 28 | ALEC | AVOID | 1.6 | GSK ended brain drug alliance on 7/9 — pipeline reset is a story stock, not a bounce trade. |
| 29 | CHGG | AVOID | 1.5 | 1wk forecast -92.85/-92.85/-92.85 and recent 'Chegg is Risky' article — the model is signaling terminal decline on the long horizon. |
| 30 | ILLR | AVOID | 1.2 | Halted on Nasdaq T12 code, reverse split authorized 1-for-10, shareholder-approval compliance dispute — untradeable landmine. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord